Number of Participants With Adverse Events for Long Term Safety and Tolerability [clinicaltrials_resource:NCT00191386/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Number of Participants With Adverse Events for Long Term Safety and Tolerability [clinicaltrials_resource:NCT00191386/outcome/1]
Bio2RDF identifier
NCT00191386/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00191386/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
All patients who took at least ...... n the analyses of safety data.
Full Analysis Set: Participant ...... ent in each assessment period.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
Baseline through 4 years
Baseline, 6 Months, 12 Months, 2 Years, 3 Years, 4 Years
Over 1 year
type [clinicaltrials_vocabulary:type]
alternate
Number of Participants With Adverse Events for Long Term Safety and Tolerability
@en
identifier
clinicaltrials_resource:NCT00191386/outcome/1
title
Details on the actual adverse ...... ported Adverse Events Section.
@en
type
label
Number of Participants With Ad ...... esource:NCT00191386/outcome/1]
@en